Edition:
United States

AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,530.50GBp
17 Jan 2017
Change (% chg)

-- (--)
Prev Close
4,530.50p
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,973,760
52-wk High
5,505.00p
52-wk Low
3,680.00p

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.93 December 18 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 10 10 7 6
(2) OUTPERFORM 9 8 10 9
(3) HOLD 9 10 12 13
(4) UNDERPERFORM 2 2 2 3
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.10 2.13 2.29 2.42

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 4 5,438.57 5,523.00 5,375.00 5,998.00
Quarter Ending Jun-17 4 5,350.87 5,440.46 5,270.00 5,994.27
Year Ending Dec-17 33 21,701.20 24,437.00 19,230.00 23,179.40
Earnings (per share)
Quarter Ending Mar-17 5 0.93 0.99 0.88 --
Quarter Ending Jun-17 5 0.90 1.04 0.82 --
Year Ending Dec-17 34 3.72 4.82 2.33 4.00
LT Growth Rate (%) 5 3.34 5.60 0.30 -0.69

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 5,903.00 5,699.00 204.00 3.46
Quarter Ending Jun-16 5,575.49 5,603.00 27.51 0.49
Quarter Ending Mar-16 5,959.64 6,115.00 155.36 2.61
Quarter Ending Dec-15 6,292.74 6,207.00 85.74 1.36
Quarter Ending Sep-15 5,967.90 5,945.00 22.90 0.38
Earnings (per share)
Quarter Ending Sep-16 0.97 1.32 0.35 36.28
Quarter Ending Jun-16 0.84 0.83 0.01 0.82
Quarter Ending Mar-16 0.94 0.95 0.01 0.57
Quarter Ending Dec-15 0.95 0.94 0.01 1.17
Quarter Ending Sep-15 1.02 1.03 0.01 0.55

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 5,438.57 5,453.51 5,453.51 5,654.12 5,998.00
Quarter Ending Jun-17 5,350.87 5,368.28 5,368.28 5,404.31 5,994.27
Year Ending Dec-17 21,701.20 21,806.10 21,861.90 22,189.10 23,179.40
Earnings (per share)
Quarter Ending Mar-17 0.93 0.92 0.92 0.96 --
Quarter Ending Jun-17 0.90 0.88 0.88 0.88 --
Year Ending Dec-17 3.72 3.74 3.75 3.79 4.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 1 1 1 1
Quarter Ending Jun-17 1 1 1 1
Year Ending Dec-17 1 4 1 5
Earnings
Quarter Ending Mar-17 1 1 1 1
Quarter Ending Jun-17 1 1 1 1
Year Ending Dec-17 1 2 1 3